Frontage Laboratories, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 760 Pennsylvania Dr, Exton, Pennsylvania (PA) 19341-1129, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 3006799640 · DUNS 832653625
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-04-14
- NAIBioresearch Monitoring2025-09-05
- NAIBioresearch Monitoring2023-03-31
- VAIDrug Quality Assurance2021-10-15
- NAIDrug Quality Assurance2019-11-01
- NAIBioresearch Monitoring2018-04-20
- VAIDrug Quality Assurance2016-03-18
- NAIDrug Quality Assurance2016-03-17
- NAIDrug Quality Assurance2013-08-30
- NAIDrug Quality Assurance2012-01-17
- NAIDrug Quality Assurance2011-04-05
- NAIDrug Quality Assurance2010-03-19
- NAIDrug Quality Assurance2009-04-07
Drugs this plant is listed as making
3 distinct drugs across 3 products name this site in their FDA label.
- dordaviproneJazz Pharmaceuticals, Inc.
- oritavancinMelinta Therapeutics, LLC
- oritavancin diphosphateMelinta Therapeutics, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.